Related Experiment Videos
Evaluation of intravascular low-osmolality contrast agents
Clinical Pharmacy
|November 1, 1986
Summary
New low-osmolality contrast agents offer reduced physiological risks compared to conventional ionic media. Their selective use in high-risk patients is recommended due to lower osmolality and fewer adverse effects.
Area of Science:
- Radiology
- Medical Imaging
- Pharmacology
Background:
- Conventional ionic contrast media carry risks of hyperosmolarity-induced reactions.
- Newer low-osmolality agents, including iohexol, iopamidol, and ioxaglate meglumine-sodium, are now available.
- These agents have significantly lower osmolality than traditional contrast media.
Purpose of the Study:
- To review the chemistry of low-osmolality contrast agents.
- To compare their physiological effects with conventional ionic contrast media.
- To provide guidelines for intravascular use in high-risk patients.
Main Methods:
- Review of existing literature on low-osmolality contrast agents.
- Comparison of osmolality and physiological effects (vascular, organ) between new and conventional agents.
- Development of a scoring system for identifying high-risk patients.
Main Results:
- Low-osmolality agents have approximately one-third the osmolality of conventional ionic media per iodine concentration.
- Reduced incidence of hypersensitivity reactions, vessel dilation, pain, and discomfort.
- Lower risk of renal vasoconstriction, hemodynamic alterations, and neurotoxicity.
Conclusions:
- Low-osmolality contrast agents offer improved safety profiles with fewer adverse physiological effects.
- Selective use in high-risk patients is advised due to higher costs.
- A scoring system aids in identifying patients who would benefit most from these agents.